Wyeth Pharmaceuticals

CDC: Vaccine shortage likely

Published in Medical Device Business Week, January 12th, 2004

The U.S. could face shortages of a popular childhood meningitis vaccine in 2004 because of production problems, federal officials say.

Prevnar, also known as PCV7, is used to protect children against invasive pneumococcal disease, which can lead to meningitis or bloodstream infections.

A 1-week production stoppage in November month to improve the process that fills vials with vaccine has caused a ripple effect that may lead to delays in the shipping of Prevnar early in 2004, said Doug Petkus, spokesman for Collegeville, Pennsylvania-based drug maker Wyeth Pharmaceuticals.

"That type of stoppage tends to create bottlenecks in our...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Device Business Week

Source: Medical Device Business Week (2004-01-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry